Korean J Hematol 2006; 41(1):
Published online March 30, 2006
https://doi.org/10.5045/kjh.2006.41.1.46
© The Korean Society of Hematology
김정훈, 이우인, 박수연, 윤휘중, 강소영, 서진태
경희대학교 의과대학, 진단검사의학교실, 내과학교실
Acute lymphoblastic leukemia with maturation (ALLm) has different disease characteristics that does typical ALL. ALLm is characterized by an increased number of mature appearing leukemic cells (>20% of ANCs in the BM) having differentiation beyond the prolymphocyte stage according to light microscopic (LM) examination. It also has a worse prognosis than typical ALL. We have recently experienced a case of ALLm and we report on this case along with a literature review. A 36 year old patient showed lymphoblasts and mature appearing leukemic cells that were counted up to 15.8% and 23.0%, respectively, of the WBCs on bone marrow examination. Despite their mature appearance, these cells showed positivity for Tdt, CD10, CD19 and HLA-DR on the immunophenotypic study. Differentiating the mature-appearing leukemic cells from the hematogones or mature lymphocytes is difficult, and only through immunophenotypic examination is it possible to discriminate ALLm from typical ALL. We suggest performing a leukemic marker study that includes CD38 to effectively differentiate mature appearing leukemic cells from hematogones, especially for the follow up of leukemia with mature appearing cells.
Keywords ALLm, Tdt, CD10, CD19, CD38 and HLA-DR
Korean J Hematol 2006; 41(1): 46-50
Published online March 30, 2006 https://doi.org/10.5045/kjh.2006.41.1.46
Copyright © The Korean Society of Hematology.
김정훈, 이우인, 박수연, 윤휘중, 강소영, 서진태
경희대학교 의과대학, 진단검사의학교실, 내과학교실
Jeong Hun Kim, Woo In Lee, Su Yon Park, Hwi Joong Yoon, So Young Kang, Jin Tae Suh
Departments of, Laboratory Medicine and, Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea
Acute lymphoblastic leukemia with maturation (ALLm) has different disease characteristics that does typical ALL. ALLm is characterized by an increased number of mature appearing leukemic cells (>20% of ANCs in the BM) having differentiation beyond the prolymphocyte stage according to light microscopic (LM) examination. It also has a worse prognosis than typical ALL. We have recently experienced a case of ALLm and we report on this case along with a literature review. A 36 year old patient showed lymphoblasts and mature appearing leukemic cells that were counted up to 15.8% and 23.0%, respectively, of the WBCs on bone marrow examination. Despite their mature appearance, these cells showed positivity for Tdt, CD10, CD19 and HLA-DR on the immunophenotypic study. Differentiating the mature-appearing leukemic cells from the hematogones or mature lymphocytes is difficult, and only through immunophenotypic examination is it possible to discriminate ALLm from typical ALL. We suggest performing a leukemic marker study that includes CD38 to effectively differentiate mature appearing leukemic cells from hematogones, especially for the follow up of leukemia with mature appearing cells.
Keywords: ALLm, Tdt, CD10, CD19, CD38 and HLA-DR
Jun Ho Yi
Blood Res 2021; 56(S1): S1-S4Jung Jun Bae, Yeo Soon Jang, Jung Yun Kim, Yeon Jung Lim, Hyun Kyung Park, Jin Yeong Han, Young Ho Lee
Korean J Hematol 2007; 42(3): 206-215Kyeong Hee Kim, Tae Gyeom Kim, Jin Yeong Han, Jung Man Kim, Jae Seok Kim, Hyo Jin Kim, Young Ho Lee, Eun Yup Lee
Korean J Hematol 1999; 34(1): 18-26